BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ramos-Álvarez I, Moreno P, Mantey SA, Nakamura T, Nuche-Berenguer B, Moody TW, Coy DH, Jensen RT. Insights into bombesin receptors and ligands: Highlighting recent advances. Peptides 2015;72:128-44. [PMID: 25976083 DOI: 10.1016/j.peptides.2015.04.026] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Alhaj-suliman SO, Wafa EI, Salem AK. Engineering nanosystems to overcome barriers to cancer diagnosis and treatment. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2022.114482] [Reference Citation Analysis]
2 Wang H, Rong J, Zhao Q, Song C, Zhao R, Chen S, Xie Y, Su T. Identification and Validation of Immune Cells and Hub Genes in Gastric Cancer Microenvironment. Disease Markers 2022;2022:1-18. [DOI: 10.1155/2022/8639323] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 de Sousa NA, Marani MM, Lopes ALF, Silva EM, Barbosa EA, Vasconcelos AG, Kuzniewski FTB, Lustosa SS, Gomes KP, Colugnati DB, Rocha JA, Santos LH, Benquerer MP, Quelemes P, Véras L, Moreira DC, Gadelha KKL, Magalhães PJC, Plácido A, Eaton P, Nicolau L, Medeiros JVR, Leite JRSA. BR-bombesin: a novel bombesin-related peptide from the skin secretion of the Chaco tree frog (Boana raniceps) with physiological gastric effects. Amino Acids. [DOI: 10.1007/s00726-021-03114-4] [Reference Citation Analysis]
4 Morgado-Valle C, Smith JC, Fernandez-Ruiz J, Lopez-Meraz L, Beltran-Parrazal L. Modulation of inspiratory burst duration and frequency by bombesin in vitro. Pflugers Arch 2022. [PMID: 35066612 DOI: 10.1007/s00424-022-02663-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Michalski K, Kemna L, Asberger J, Grosu AL, Meyer PT, Ruf J, Sprave T. Gastrin-Releasing Peptide Receptor Antagonist [68Ga]RM2 PET/CT for Staging of Pre-Treated, Metastasized Breast Cancer. Cancers (Basel) 2021;13:6106. [PMID: 34885214 DOI: 10.3390/cancers13236106] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Mansi R, Nock BA, Dalm SU, Busstra MB, van Weerden WM, Maina T. Radiolabeled Bombesin Analogs. Cancers (Basel) 2021;13:5766. [PMID: 34830920 DOI: 10.3390/cancers13225766] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
7 Nock BA, Kaloudi A, Kanellopoulos P, Janota B, Bromińska B, Iżycki D, Mikołajczak R, Czepczynski R, Maina T. [99mTc]Tc-DB15 in GRPR-Targeted Tumor Imaging with SPECT: From Preclinical Evaluation to the First Clinical Outcomes. Cancers (Basel) 2021;13:5093. [PMID: 34680243 DOI: 10.3390/cancers13205093] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Moody TW, Lee L, Ramos-Alvarez I, Iordanskaia T, Mantey SA, Jensen RT. Bombesin Receptor Family Activation and CNS/Neural Tumors: Review of Evidence Supporting Possible Role for Novel Targeted Therapy. Front Endocrinol (Lausanne) 2021;12:728088. [PMID: 34539578 DOI: 10.3389/fendo.2021.728088] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Vahidfar N, Aghanejad A, Ahmadzadehfar H, Farzanehfar S, Eppard E. Theranostic Advances in Breast Cancer in Nuclear Medicine. Int J Mol Sci 2021;22:4597. [PMID: 33925632 DOI: 10.3390/ijms22094597] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
10 Mitran B, Tolmachev V, Orlova A. Radiolabeled GRPR Antagonists for Imaging of Disseminated Prostate Cancer - Influence of Labeling Chemistry on Targeting Properties. Curr Med Chem 2020;27:7090-111. [PMID: 32164503 DOI: 10.2174/0929867327666200312114902] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Baun C, Mitran B, Rinne SS, Dam JH, Olsen BB, Tolmachev V, Orlova A, Thisgaard H. Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer. Molecules 2020;25:E5993. [PMID: 33352838 DOI: 10.3390/molecules25245993] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kręcisz P, Czarnecka K, Królicki L, Mikiciuk-Olasik E, Szymański P. Radiolabeled Peptides and Antibodies in Medicine. Bioconjug Chem 2021;32:25-42. [PMID: 33325685 DOI: 10.1021/acs.bioconjchem.0c00617] [Cited by in Crossref: 3] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
13 Barrabés S, Ng-Choi I, Martínez MÁ, Manzano BR, Jalón FA, Espino G, Feliu L, Planas M, de Llorens R, Massaguer A. A nucleus-directed bombesin derivative for targeted delivery of metallodrugs to cancer cells. J Inorg Biochem 2020;212:111214. [PMID: 32919249 DOI: 10.1016/j.jinorgbio.2020.111214] [Reference Citation Analysis]
14 Rasaeifar B, Gomez-Gutierrez P, Perez JJ. New Insights into the Stereochemical Requirements of the Bombesin BB1 Receptor Antagonists Binding. Pharmaceuticals (Basel) 2020;13:E197. [PMID: 32824403 DOI: 10.3390/ph13080197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Abou D, Benabdallah N, Jiang W, Peng L, Zhang H, Villmer A, Longtine MS, Thorek DLJ. Prostate Cancer Theranostics - An Overview. Front Oncol 2020;10:884. [PMID: 32582550 DOI: 10.3389/fonc.2020.00884] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
16 Kasprzak A, Adamek A. The Neuropeptide System and Colorectal Cancer Liver Metastases: Mechanisms and Management. Int J Mol Sci 2020;21:E3494. [PMID: 32429087 DOI: 10.3390/ijms21103494] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
17 Worm DJ, Els‐heindl S, Beck‐sickinger AG. Targeting of peptide‐binding receptors on cancer cells with peptide‐drug conjugates. Peptide Science 2020;112. [DOI: 10.1002/pep2.24171] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
18 Michalski K, Stoykow C, Bronsert P, Juhasz-Böss I, Meyer PT, Ruf J, Erbes T, Asberger J. Association between gastrin-releasing peptide receptor expression as assessed with [68Ga]Ga-RM2 PET/CT and histopathological tumor regression after neoadjuvant chemotherapy in primary breast cancer. Nucl Med Biol 2020;86-87:37-43. [PMID: 32473549 DOI: 10.1016/j.nucmedbio.2020.05.003] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
19 Dong L, Zhang B, Wu L, Shang Z, Liu S, Jiang X, Wang H, Fan L, Zhang Y, Xiao H. Proteomics Analysis of Cellular BRS3 Receptor Activation Reveals Potential Mechanism for Signal Transduction and Cell Proliferation. J Proteome Res 2020;19:1513-21. [PMID: 32091899 DOI: 10.1021/acs.jproteome.9b00760] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
20 Baratto L, Duan H, Mäcke H, Iagaru A. Imaging the Distribution of Gastrin-Releasing Peptide Receptors in Cancer. J Nucl Med 2020;61:792-8. [DOI: 10.2967/jnumed.119.234971] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
21 Li M, Liang P, Liu D, Yuan F, Chen GC, Zhang L, Liu Y, Liu H. Bombesin Receptor Subtype-3 in Human Diseases. Arch Med Res 2019;50:463-7. [PMID: 31911345 DOI: 10.1016/j.arcmed.2019.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
22 Hoppenz P, Els-Heindl S, Kellert M, Kuhnert R, Saretz S, Lerchen HG, Köbberling J, Riedl B, Hey-Hawkins E, Beck-Sickinger AG. A Selective Carborane-Functionalized Gastrin-Releasing Peptide Receptor Agonist as Boron Delivery Agent for Boron Neutron Capture Therapy. J Org Chem 2020;85:1446-57. [PMID: 31813224 DOI: 10.1021/acs.joc.9b02406] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
23 Lee L, Ramos-Alvarez I, Moody TW, Mantey SA, Jensen RT. Neuropeptide bombesin receptor activation stimulates growth of lung cancer cells through HER3 with a MAPK-dependent mechanism. Biochim Biophys Acta Mol Cell Res 2020;1867:118625. [PMID: 31862538 DOI: 10.1016/j.bbamcr.2019.118625] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
24 Ma Z, Guo J, Zhang Y, Zhang Y, Zhang M, Zong R, Chen F, Zhang J. Neuromedin B regulates steroidogenesis, cell viability and apoptosis in rabbit Leydig cells. Gen Comp Endocrinol 2020;288:113371. [PMID: 31857076 DOI: 10.1016/j.ygcen.2019.113371] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Sommer AK, Falcenberg M, Ljepoja B, Fröhlich T, Arnold GJ, Wagner E, Roidl A. Downregulation of GRK5 hampers the migration of breast cancer cells. Sci Rep 2019;9:15548. [PMID: 31664083 DOI: 10.1038/s41598-019-51923-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
26 Wang P, Zhang L, Li H, Wang Y, Zhang S, Liu Z. Characterization of GRP as a functional neuropeptide in basal chordate amphioxus. Int J Biol Macromol 2020;142:384-94. [PMID: 31593737 DOI: 10.1016/j.ijbiomac.2019.09.109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
27 Pooja D, Gunukula A, Gupta N, Adams DJ, Kulhari H. Bombesin receptors as potential targets for anticancer drug delivery and imaging. The International Journal of Biochemistry & Cell Biology 2019;114:105567. [DOI: 10.1016/j.biocel.2019.105567] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
28 Li L, Wu C, Pan L, Li X, Kuang A, Cai H, Tian R. Bombesin-functionalized superparamagnetic iron oxide nanoparticles for dual-modality MR/NIRFI in mouse models of breast cancer. Int J Nanomedicine 2019;14:6721-32. [PMID: 31686805 DOI: 10.2147/IJN.S211476] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
29 Oliveira MC, Correia JDG. Biomedical applications of radioiodinated peptides. Eur J Med Chem 2019;179:56-77. [PMID: 31238251 DOI: 10.1016/j.ejmech.2019.06.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
30 Hlapisi N, Motaung TE, Linganiso LZ, Oluwafemi OS, Songca SP. Encapsulation of Gold Nanorods with Porphyrins for the Potential Treatment of Cancer and Bacterial Diseases: A Critical Review. Bioinorg Chem Appl 2019;2019:7147128. [PMID: 31182957 DOI: 10.1155/2019/7147128] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
31 Ramos-Alvarez I, Lee L, Mantey SA, Jensen RT. Development and Characterization of a Novel, High-Affinity, Specific, Radiolabeled Ligand for BRS-3 Receptors. J Pharmacol Exp Ther 2019;369:454-65. [PMID: 30971479 DOI: 10.1124/jpet.118.255141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
32 Tighe RM, Heck K, Soderblom E, Zhou S, Birukova A, Young K, Rouse D, Vidas J, Komforti MK, Toomey CB, Cuttitta F, Sunday ME. Immediate Release of Gastrin-Releasing Peptide Mediates Delayed Radiation-Induced Pulmonary Fibrosis. Am J Pathol 2019;189:1029-40. [PMID: 30898588 DOI: 10.1016/j.ajpath.2019.01.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
33 Gnesin S, Cicone F, Mitsakis P, Van der Gucht A, Baechler S, Miralbell R, Garibotto V, Zilli T, Prior JO. First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist 68Ga-NODAGA-MJ9. EJNMMI Res 2018;8:108. [PMID: 30543050 DOI: 10.1186/s13550-018-0462-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
34 Shirey KA, Sunday ME, Lai W, Patel MC, Blanco JCG, Cuttitta F, Vogel SN. Novel role of gastrin releasing peptide-mediated signaling in the host response to influenza infection. Mucosal Immunol 2019;12:223-31. [PMID: 30327535 DOI: 10.1038/s41385-018-0081-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
35 Atanasova KR, Reznikov LR. Neuropeptides in asthma, chronic obstructive pulmonary disease and cystic fibrosis. Respir Res 2018;19:149. [PMID: 30081920 DOI: 10.1186/s12931-018-0846-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
36 Ma Z, Zhang Y, Su J, Yang S, Qiao W, Li X, Lei Z, Cheng L, An N, Wang W, Feng Y, Zhang J. Effects of neuromedin B on steroidogenesis, cell proliferation and apoptosis in porcine Leydig cells. Journal of Molecular Endocrinology 2018;61:13-23. [DOI: 10.1530/jme-17-0242] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
37 Matters GL, Harms JF. Utilizing Peptide Ligand GPCRs to Image and Treat Pancreatic Cancer. Biomedicines 2018;6:E65. [PMID: 29865257 DOI: 10.3390/biomedicines6020065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
38 Moreno P, Mantey SA, Lee SH, Ramos-Álvarez I, Moody TW, Jensen RT. A possible new target in lung-cancer cells: The orphan receptor, bombesin receptor subtype-3. Peptides 2018;101:213-26. [PMID: 29410320 DOI: 10.1016/j.peptides.2018.01.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
39 Ma Z, Zhang Y, Su J, Li X, Yang S, Qiao W, Suo C, Lei Z. Distribution of the pig gastrin-releasing peptide receptor and the effect of GRP on porcine Leydig cells. Peptides 2018;99:142-52. [DOI: 10.1016/j.peptides.2017.09.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
40 Maruyama M, Hotta N, Nio Y, Hamagami K, Nagi T, Funata M, Sakamoto J, Nakakariya M, Amano N, Nishida M, Okawa T, Arikawa Y, Sasaki S, Kasai S, Nagisa Y, Habata Y, Mori M. Bombesin receptor subtype-3-expressing neurons regulate energy homeostasis through a novel neuronal pathway in the hypothalamus. Brain Behav 2018;8:e00881. [PMID: 29568682 DOI: 10.1002/brb3.881] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
41 Hauser AS, Attwood MM, Rask-Andersen M, Schiöth HB, Gloriam DE. Trends in GPCR drug discovery: new agents, targets and indications. Nat Rev Drug Discov 2017;16:829-42. [PMID: 29075003 DOI: 10.1038/nrd.2017.178] [Cited by in Crossref: 875] [Cited by in F6Publishing: 962] [Article Influence: 175.0] [Reference Citation Analysis]
42 Tornesello AL, Buonaguro L, Tornesello ML, Buonaguro FM. New Insights in the Design of Bioactive Peptides and Chelating Agents for Imaging and Therapy in Oncology. Molecules 2017;22:E1282. [PMID: 28767081 DOI: 10.3390/molecules22081282] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
43 Moody TW, Tashakkori N, Mantey SA, Moreno P, Ramos-Alvarez I, Leopoldo M, Jensen RT. AM-37 and ST-36 Are Small Molecule Bombesin Receptor Antagonists. Front Endocrinol (Lausanne) 2017;8:176. [PMID: 28785244 DOI: 10.3389/fendo.2017.00176] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
44 Lin Y, Chen T, Zhou M, Wang L, Su S, Shaw C. Ranatensin-HL: A Bombesin-Related Tridecapeptide from the Skin Secretion of the Broad-Folded Frog, Hylarana latouchii. Molecules 2017;22:E1110. [PMID: 28677620 DOI: 10.3390/molecules22071110] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
45 Maina T, Kaloudi A, Valverde IE, Mindt TL, Nock BA. Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors. Nucl Med Biol 2017;52:57-62. [PMID: 28636973 DOI: 10.1016/j.nucmedbio.2017.06.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
46 Khan M, Huang T, Lin CY, Wu J, Fan BM, Bian ZX. Exploiting cancer's phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy. Oncotarget 2017;8:104615-37. [PMID: 29262666 DOI: 10.18632/oncotarget.18403] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
47 Czepielewski RS, Jaeger N, Marques PE, Antunes MM, Rigo MM, Alvarenga DM, Pereira RV, da Silva RD, Lopes TG, da Silva VD, Porto BN, Menezes GB, Bonorino C. GRPR antagonist protects from drug-induced liver injury by impairing neutrophil chemotaxis and motility. Eur J Immunol 2017;47:646-57. [DOI: 10.1002/eji.201646394] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
48 Morgat C, Macgrogan G, Brouste V, Vélasco V, Sévenet N, Bonnefoi H, Fernandez P, Debled M, Hindié E. Expression of Gastrin-Releasing Peptide Receptor in Breast Cancer and Its Association with Pathologic, Biologic, and Clinical Parameters: A Study of 1,432 Primary Tumors. J Nucl Med 2017;58:1401-7. [DOI: 10.2967/jnumed.116.188011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 7.4] [Reference Citation Analysis]
49 Mansour N, Dumulon-perreault V, Ait-mohand S, Paquette M, Lecomte R, Guérin B. Impact of dianionic and dicationic linkers on tumor uptake and biodistribution of [ 64 Cu]Cu/NOTA peptide-based gastrin-releasing peptide receptors antagonists. J Label Compd Radiopharm 2017;60:200-12. [DOI: 10.1002/jlcr.3491] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
50 Mion G, Mari C, Da ros T, Rubbiani R, Gasser G, Gianferrara T. Towards the Synthesis of New Tumor Targeting Photosensitizers for Photodynamic Therapy and Imaging Applications. ChemistrySelect 2017;2:190-200. [DOI: 10.1002/slct.201601960] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
51 Ferreira CA, Fuscaldi LL, Townsend DM, Rubello D, Barros ALB. Radiolabeled bombesin derivatives for preclinical oncological imaging. Biomed Pharmacother 2017;87:58-72. [PMID: 28040598 DOI: 10.1016/j.biopha.2016.12.083] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
52 Moody TW, Nuche-Berenguer B, Jensen RT. Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer. Curr Opin Endocrinol Diabetes Obes 2016;23:38-47. [PMID: 26702849 DOI: 10.1097/MED.0000000000000218] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 10.3] [Reference Citation Analysis]
53 Washington MC, Mhalhal TR, Sayegh AI. The BB2 receptor antagonist BW2258U89 attenuates the feeding responses evoked by exogenous gastrin releasing peptide-29. Horm Behav 2016;85:1-4. [PMID: 27381650 DOI: 10.1016/j.yhbeh.2016.06.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
54 Nakamura T, Ramos-Álvarez I, Iordanskaia T, Moreno P, Mantey SA, Jensen RT. Molecular basis for high affinity and selectivity of peptide antagonist, Bantag-1, for the orphan BB3 receptor. Biochem Pharmacol 2016;115:64-76. [PMID: 27346274 DOI: 10.1016/j.bcp.2016.06.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
55 Bell AM, Gutierrez-Mecinas M, Polgár E, Todd AJ. Spinal neurons that contain gastrin-releasing peptide seldom express Fos or phosphorylate extracellular signal-regulated kinases in response to intradermal chloroquine. Mol Pain 2016;12:1744806916649602. [PMID: 27270268 DOI: 10.1177/1744806916649602] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
56 Gilad Y, Firer M, Gellerman G. Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer Cells. Biomedicines 2016;4:E11. [PMID: 28536378 DOI: 10.3390/biomedicines4020011] [Cited by in Crossref: 49] [Cited by in F6Publishing: 52] [Article Influence: 8.2] [Reference Citation Analysis]
57 Moreno P, Ramos-Álvarez I, Moody TW, Jensen RT. Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment. Expert Opin Ther Targets 2016;20:1055-73. [PMID: 26981612 DOI: 10.1517/14728222.2016.1164694] [Cited by in Crossref: 50] [Cited by in F6Publishing: 62] [Article Influence: 8.3] [Reference Citation Analysis]
58 Ramos-Álvarez I, Nakamura T, Mantey SA, Moreno P, Nuche-Berenguer B, Jensen RT. Novel chiral-diazepines function as specific, selective receptor agonists with variable coupling and species variability in human, mouse and rat BRS-3 receptor cells. Peptides 2016;75:8-17. [PMID: 26524625 DOI: 10.1016/j.peptides.2015.10.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
59 Pan W. Festschrift to highlight the career of Abba J. Kastin as a founding editor, researcher, and educator in the peptide field. Preface. Peptides 2015;72:1-3. [PMID: 26275336 DOI: 10.1016/j.peptides.2015.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
60 González N, Moreno P, Jensen RT. Bombesin receptor subtype 3 as a potential target for obesity and diabetes. Expert Opin Ther Targets 2015;19:1153-70. [PMID: 26066663 DOI: 10.1517/14728222.2015.1056154] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]